Clinical Trial Update: PDE5-Inhibition With Sildenafil in Chronic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial of sildenafil, a PDE5 inhibitor, for chronic heart failure has completed. The update notes completion status but does not include trial results in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Milan | Conditions: Heart Failure | Phase 3 | Status: COMPLETED